8:308:45Welcome and IntroductionDr. Harvey Fineberg
President, Institute of Medicine
8:459:00WelcomeHonorable Michael O. Leavitt
Secretary, U.S. Department of Health and Human Services
9:009:15Meeting ObjectivesDr. Bruce Gellin
Director, National Vaccine Program Office
9:159:45Current Status of Avian Influenza and Pandemic ThreatDr. Julie Gerberding
Director, Centers for Disease Control and Prevention
9:4510:15Meeting the Challenge of Pandemic Vaccine Preparedness: An FDA PerspectiveDr. Jesse Goodman
Director, Center for Biologics Evaluation and Review
U.S. Food and Drug Administration
10:1510:45Global Pandemic Preparedness Research EffortsDr. Klaus Stohr
Global Influenza Programme, World Health Organization
10:4511:00DiscussionDr. Harvey Fineberg
11:0011:30The Role of NIH Research in Pandemic Influenza PreparednessDr. Anthony Fauci
Director, National Institute of Allergy and Infectious Disease, National Institutes of Health
11:303:30Concurrent break-out groups 1-4 (with working lunch)
Group 1 (NAS Room 150):Influenza Virulence and Antigenic Change
Group 2 (NAS Board Room):Controlling Animal Influenza and Decreasing Animal-to-Human Transmission
Group 3 (NAS Lecture Room):Influenza Diagnostics for Surveillance
Group 4 (NAS Members Room):Treatments and Immunotherapies – Antivirals and Non-Specific Approaches
3:305:30Working group 1,2,3,4 reports to the plenaryDr. Harvey Fineberg
6:009:00Reception in the Great Hall

From: 1, Introduction

Cover of John R. La Montagne Memorial Symposium on Pandemic Influenza Research
John R. La Montagne Memorial Symposium on Pandemic Influenza Research: Meeting Proceedings.
Institute of Medicine (US) Board on Population Health and Public Health Practice.
Washington (DC): National Academies Press (US); 2005.
Copyright © 2005, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.